IMMX Nov 2024 7.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:29PM EDT. Market open.
| Previous close | 0.3300 |
| Open | 0.3300 |
| Bid | 0.0000 |
| Ask | 4.8000 |
| Strike | 7.50 |
| Expiry date | 2024-11-15 |
| Day's range | 0.3300 - 0.3300 |
| Contract range | N/A |
| Volume | |
| Open interest | 100 |
Simply Wall St.Is Immix Biopharma (NASDAQ:IMMX) In A Good Position To Invest In Growth?
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
GlobeNewswireImmix Biopharma to Present at the Stifel 2024 Cell Therapy Forum
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or “IMMX”), a clinical-stage biopharmaceutical company trailblazing cell therapies in autoimmune disease, today announced that it will present and host institutional investor meetings at the Stifel 2024 Cell Therapy Forum. Stifel 2024 Cell Therapy Forum - Immix Biopharma Date:Tuesday, July 9, 2024Presentation: Immix Biopharma to presentLocation:VirtualInvestor Meetings:The IMMX Team will be
- Simply Wall St.
Immix Biopharma Insiders Placed Bullish Bets Worth US$625.7k
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
© 2024 Yahoo. All rights reserved.